Clinical Trial Update: A Study to Assess the Effect of Maintenance Treatment With Rituximab Versus No Treatment in Participants With Progressive B-Cell Chronic Lymphocytic Leukemia (CLL) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating maintenance rituximab versus no treatment in progressive chronic lymphocytic leukemia; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphocytic Leukemia, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2018-08-20